论文部分内容阅读
目的观察国产雷帕霉素药物洗脱支架(Partner)对急性心肌梗死(AMI)的临床疗效。方法将2005年5月至2006年8月天津武警医学院附属医院心内科116例AMI行急诊经皮冠状动脉介入治疗(PCI)的患者,依所置入支架不同,分为进口Cypher组(n=52)和国产Partner组(n=64)。观察两组患者住院及随访期间主要心脏不良事件(MACE)的发生和血管再狭窄情况。结果两组患者梗死相关动脉的分布差异无显著性意义。Cypher组置入支架55枚,Partner组置入支架64枚。所有患者急诊PCI手术均成功,住院及随访期间无MACE发生。Cypher组11例(21.15%)、Partner组18例(28.13%)完成了6个月冠脉造影随访,再狭窄率均为0。结论国产雷帕霉素药物洗脱支架应用于AMI治疗安全、有效。
Objective To observe the clinical effect of domestic rapamycin-eluting stent on acute myocardial infarction (AMI). Methods From May 2005 to August 2006, patients with acute myocardial infarction (AMI) who underwent AMI in the Department of Cardiology, Affiliated Hospital of Tianjin Armed Police Medical College from November 2005 to August 2006 were divided into two groups according to the stents: = 52) and domestic Partner group (n = 64). The occurrence of major cardiac adverse events (MACEs) and restenosis during hospitalization and follow-up in both groups were observed. Results There was no significant difference in the distribution of infarction-related arteries between the two groups. The Cypher group included 55 stents and the Partner group housed 64 stents. Emergency PCI was performed successfully in all patients and no MACE occurred during hospitalization and follow-up. Eleven patients (21.15%) in the Cypher group and 18 patients (28.13%) in the Partner group completed 6-month coronary angiography follow-up, with a restenosis rate of 0. Conclusion The domestic rapamycin-eluting stent is safe and effective for AMI.